US Stock MarketDetailed Quotes

OPTN OptiNose

Watchlist
  • 0.538
  • +0.038+7.58%
Close Dec 2 16:00 ET
  • 0.538
  • 0.0000.00%
Post 20:01 ET
81.15MMarket Cap-1855P/E (TTM)

About OptiNose Company

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Company Profile

SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees132
Fiscal Year Ends12-31
Address777 Township Line Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ramy A. Mahmoud, M.D.
  • Chief Executive Officer and Director
  • 2.41M
  • P. Terence Kohler, Jr
  • Chief Financial Officer
  • --
  • Michael F. Marino, III,
  • Chief Legal Officer and Corporate Secretary
  • 1.32M
  • Anthony J. Krick
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Paul Spence, Jr
  • Chief Commercial Officer
  • 664.02K
  • R. John Fletcher
  • Chairman of the Board
  • 120.22K
  • Kyle Dempsey
  • Independent Director
  • 90.92K
  • Wilhelmus C. M. Groenhuysen
  • Independent Director
  • 100.92K
  • Sandra L. Helton
  • Independent Director
  • 103.42K
  • Tomas J. Heyman
  • Independent Director
  • 96.88K
  • Dr. Eric Bednarski
  • Independent Director
  • 88.42K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data